Cardinal offers $400m for Intercare
Cardinal Health has entered into a $400 million deal to acquire
Intercare Group of the UK that would provide it with a
significantly-expanded presence in the European market.
Amersham comes in on track in 3Q
Amersham yesterday gave a third quarter trading update in the
build-up to its proposed $9.5 billion (€8.1bn) acquisition by
Eppendorf doubles up for gene expression
German instrument, consumable and reagent company Eppendorf has
introduced a new range of low-density DNA microarrays for
differential gene expression analyses.
Smoother lipid delivery
The healthcare division of UK-based speciality chemicals maker
Croda Chemicals Europe used the CPhI exhibition in Frankfurt this
week as a platform to launch two new excipients for drug delivery.
Closer EU/US ties
The EU and US move a small step closer to a harmonised regulatory
system with the first-ever collaboration on the review of
scientific data in an application to start a clinical trial.
Funds raised for T cell research
Danish biotech company T-cellic has just completed its second round
of financing, raising DK 40 million (€5.4m) in a deal that will set
the company up to take its T cell-based technologies, used for both
the localisation and treatment...
Swedish scientists work on SLE treatment
A candidate drug for the treatment ofSystemic Lupus Erythematosus
(SLE) could inhibit the condition, reports Swedish biotech company
Funding for Phase I at FeRx
San-Diego based FeRx has received a slice of funding to support
research to evaluate the use of its MagneTarg drug delivery system
in the site-specific localisation of gemcitabine, a
chemotherapeutic agent already approved for the...
Fighting the brain drain
Steps towards enhanced harmony in the European research arena were taken yesterday when the European Commission and seven of the foremost European...
Pharmaco dives deeper into Sweden
Nordic pharmaceutical company Pharmaco forges further into Northern
Europe unveiling new sales activities in Sweden to cut into the
growing generic pharmaceutical market there.
Malaysia backs biotechnology
Misssouri-based medical genomics company GenoMed will link up with
Malaysian company PhenoMed, encouraged by the Malaysian government
currently keen to push biotechnology advances in the country.
Peptides from Solutia
Solutia has launched an offensive on the outsourced peptide
synthesis market with the formation of a new business group in
Switzerland focusing on the sector.
Purification market getting crowded
The market for protein and DNA purification kits is maturing, and
the pace of technological innovation has slowed, leaving dozens of
companies jostling for market share.
Multiple gene silencing, at a stroke
An Australian company claims to have successfully achieved the
simultaneous disabling of multiple genes through its RNA
interference (RNAi) technology.
Amersham sues PE for patent infringement
Amersham Biosciences has filed a lawsuit against PerkinElmer
alleging that the latter has infringed on two of Amersham's patents
for a reagent technology used in the development of new drugs.